Fox Corporation stock analysis: a 25.2% operating margin, strong liquidity and 7.7x EV/EBITDA put FOXA right at the model’s Buy line.
Chaudhry Kramat Ali
Chaudhry Kramat Ali
Chaudhry Kramat Ali is the pen name of three doctorate-level friends with expertise spanning finance, economics, and international law. Together, they bring over 30 years of multi-disciplinary experience in value investing — analysing businesses through the lens of fundamentals, institutional ownership data, and long-term capital allocation.
-
-
Retail (Discretionary)US Stocks
Amazon’s 242% Earnings Jump Outpaces Its Operations – and Its Cash Flow
Amazon.com stock analysis: 19.6% revenue growth and a 242% earnings jump, but profit leans on non-operating gains and FCF is thin. Model: Hold.
-
SemiconductorsUS Stocks
MaxLinear Has Rallied About Tenfold From Its Low – and the Model Now Signals Sell
MaxLinear stock analysis: revenue up 55.2% but still loss-making, with shares near two-year highs at 15x EV/revenue. Model signal: Sell.
-
Getting Started
Energy Volatility in 2026: A Value Investor’s Checklist for Finding Mispriced Stocks
Learn how value investors can reassess energy stocks in 2026 using cash flow, enterprise value, and margin of safety during sector volatility.
-
Analyst Upgrades & DowngradesFeatured
Analyst Upgrades Point to a Broader Market Rotation Into Value
Analyst upgrades across financials, industrials and other value sectors signal broader market rotation as institutions reassess earnings breadth.
-
FeaturedSoftwareUS Stocks
Corpay Earns a Buy Signal on Margins and Cash Flow, With Leverage the Main Caveat
Corpay stock analysis: 80.5% gross margins and a 7.3% free cash flow yield earn a model Buy, but debt-to-equity of 2.75 and a near-high price are risks.
-
BiotechnologyUS Stocks
Faeth Therapeutics Trades Near Its Two-Year High While the Fundamentals Stay Pre-Revenue
Faeth Therapeutics stock analysis: a pre-revenue clinical biotech trading near its two-year high, with no debt, steep losses and a model rating of N/A.